Wolverine Trading
NAVB

Wolverine Trading’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Wolverine Trading’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16,297
Closed -$5K – 5251
2023
Q1 		$5K Sell
16,297
-639
-4% -$187 ﹤0.01% 4105
2022
Q4 		$4K Buy
+16,936
New +$4.24K ﹤0.01% 3840
2022
Q1 		– Sell
-12,484
Closed -$11.4K – 6987
2021
Q4 		$13K Buy
+12,484
New +$17.6K ﹤0.01% 5534
2021
Q2 		– Sell
-11,219
Closed -$22K – 7153
2021
Q1 		$22K Sell
11,219
-4,128
-27% -$9.66K ﹤0.01% 5755
2020
Q4 		$31K Buy
+15,347
New +$36.2K ﹤0.01% 4664
2020
Q3 		– Sell
-15,805
Closed -$56.7K – 5496
2020
Q2 		$60K Sell
15,805
-1,621
-9% -$3.1K ﹤0.01% 4275
2020
Q1 		$14K Buy
+17,426
New +$19.2K ﹤0.01% 4458
2017
Q4 		– Sell
-757
Closed -$6K – 5850
2017
Q3 		$6K Sell
757
-20
-3% -$169 ﹤0.01% 4326
2017
Q2 		$8K Buy
+777
New +$7.68K ﹤0.01% 4175

Other funds holding NAVB

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return

Wolverine Trading's NAVB Position: Q2 2023 in Review

Wolverine Trading sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q2 2023, closing a stake of 16,297 shares — an estimated $5K sold.

Wolverine Trading first reported a position in NAVB in Q2 2017 and held it in 9 quarters. The position peaked at $60K in Q2 2020. 23 funds tracked by Wall St. Rank hold NAVB as of Q2 2023.

  • Wolverine Trading reported no remaining Navidea Biopharmaceuticals Inc. position as of Q2 2023 after selling out during the quarter.
  • Wolverine Trading sold 16,297 Navidea Biopharmaceuticals Inc. shares in Q2 2023, an estimated $5K.
  • Wolverine Trading first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2017 and held it in 9 quarters.
  • Wolverine Trading's Navidea Biopharmaceuticals Inc. position peaked at $60K in Q2 2020.
  • 23 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q2 2023.

Based on Wolverine Trading's 13F filing for Q2 2023, filed 23 Aug 2023.